Bank Of Montreal Sorrento Therapeutics, Inc. Transaction History

Bank Of Montreal

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$0.74 - $1.83 $1,161 - $2,873	-1,570 Reduced 4.51%	33,243 $29,000
Q3 2022 Nov 10, 2022	SELL	$1.51 - $2.88 $303,198 - $578,286	-200,794 Reduced 85.22%	34,813 $73,000
Q2 2022 Aug 11, 2022	BUY	$1.24 - $2.33 $221,607 - $416,408	178,716 Added 314.14%	235,607 $492,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $90,090 - $220,720	45,045 Added 380.25%	56,891 $144,000
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.23 $7,337 - $11,408	-1,578 Reduced 11.76%	11,846 $57,000
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $24,097 - $35,739	3,252 Added 31.97%	13,424 $105,000
Q2 2021 Aug 12, 2021	BUY	$6.35 - $10.0 $64,592 - $101,720	10,172 New	10,172 $101,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.